ARK Genomic Revolution ETF | ARKG

Medium RiskEquity
ARK Genomic Revolution ETF
Issued by:ARK
Index : BATS
Unit Price (NAV) :
$
Minimum investment: 2 units
Share
Compare
Share
Compare
ARK Genomic Revolution ETF | ARKG

ARK Genomic Revolution ETF | ARKG

About ARKG ETF

Overview:
ARK Genomic Revolution ETF invests in companies which are focused on and are expected to substantially benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments and advancements in genomics into their business.
The companies held in ARKG may develop, produce or enable:

  • CRISPR
  • Targeted Therapeutics
  • Bioinformatics
  • Molecular Diagnostics
  • Stem Cells
  • Agricultural Biology
ARKG will be concentrated in issuers in any industry or group of industries in the health care sector, including issuers having their principal business activities in the biotechnology industry.
ARKG is an actively managed ETF that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

Recommended for:
Growth

Returns

PerformanceYTD1Y3Y5Y
ARK Genomic Revolution ETF-5.92%165.70%54.45%38.69%

Asset Class

Asset type breakdown
Stock US84.04%
Stock non-US15.81%
Cash0.15%

ARKG Holdings - Top 10

NameiWeightage (%)
Teladoc Health, Inc7.17%
Exact Sciences Corporation5.11%
Pacific Biosciences of California, Inc5.02%
Regeneron Pharmaceuticals, Inc4.68%
Twist Bioscience Corporation3.96%
Novartis AG3.93%
Vertex Pharmaceuticals Incorporated3.89%
Takeda Pharmaceutical Company Limited3.60%
Roche Holding AG3.46%
Fate Therapeutics, Inc3.28%

ARKG Sectors/Industry Breakdown

Sectori% of market value
Healthcare97.14%
Technology1.68%
Financial Services0.67%
Consumer Defensive0.52%

ARKG Countries

Countryi% of market value
North America84.60%
Europe Developed11%
Japan3.61%
Africa/Middle East0.79%

Projected Returns

Investment ofper month
gives returns of :
at 31.22% / annum
$in 5 years
amount
for a time period of
time1Y3Y5Y
Returnsbased on historic SIP returns of 31.22% per annum
$
$
$+ 31.22

ARKG Summary Data

Total Net Assets $i
Average Mkt Cap Mil $i
Symbol ARKG
Exchange BATS
Asset class Equity

ARKG Portfolio Data & Volatility Analysis

Net Expense Ratio 0.75i
Beta 1.58i
Valuations Rates Portfolio PE 18.49466i
3 Year Standard Deviation 38.94i

About ARK

Founded in 2014, Ark is an investment manager based out of the United States of America. Ark focuses on disruptive technologies and invests specifically in innovative companies that apply them. These technologies include artificial intelligence, DNA sequencing, gene editing, robotics, electric vehicles, energy storage, fintech, 3D printing and blockchain technology. It has also invested in cryptocurrencies.

ARK Genomic Revolution ETF | ARKG